(19)
(11) EP 4 770 724 A1

(12)

(43) Date of publication:
08.07.2026 Bulletin 2026/28

(21) Application number: 24861200.4

(22) Date of filing: 30.08.2024
(51) International Patent Classification (IPC): 
A61M 31/00(2006.01)
A61M 11/00(2006.01)
A61M 11/02(2006.01)
(52) Cooperative Patent Classification (CPC):
A61M 11/02; A61M 31/002
(86) International application number:
PCT/US2024/044815
(87) International publication number:
WO 2025/050006 (06.03.2025 Gazette 2025/10)
(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC ME MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated Extension States:
BA
Designated Validation States:
GE KH MA MD TN

(30) Priority: 01.09.2023 US 202363580213 P
21.09.2023 US 202363584466 P
31.05.2024 US 202463654834 P

(71) Applicant: Biora Therapeutics, Inc.
San Diego, CA 92122 (US)

(72) Inventors:
  • SHABRAM, Paul
    Encinitas, California 92024 (US)
  • VALENZUELA-RIVAS, Rene
    Chula Vista, California 91913 (US)
  • IBAY, Marvin
    San Diego, California 92127 (US)
  • QUINTANA, Nelson
    Temecula, California 92592 (US)
  • BLISS, Pete
    Irvine, California 92618 (US)
  • ANDERFAAS, Eric
    Irvine, California 92618 (US)
  • BARBOD, Leonard
    San Diego, California 92127 (US)
  • MCCULLOCH, Cale
    Lemon Grove, California 91945 (US)
  • AULD, Jack
    Irvine, California 92618 (US)
  • HAWARE, Rahul
    Colonia, New Jersey 07067 (US)
  • SEDLOCK, Robert
    Bethlehem, Pennsylvania 18017 (US)
  • ANDREWS, Christopher
    Lake Elsinore, California 92530 (US)

(74) Representative: Mewburn Ellis LLP 
8 Bishopsgate
London EC2N 4BQ
London EC2N 4BQ (GB)

   


(54) INGESTIBLE DRUG DELIVERY DEVICE